SUBCHONDRAL BONE MARROW LESION CEMENT OK’D IN EUROPE (Orthopedics This Week)
Graftys Website
Graftys, S.A., a company founded in 2005 and based in the university town of Aix-En-Provence, France, has a line of innovative biomaterials has received authorization to commercialize two new cements to treat bone marrow lesions caused by traumatic injury.
The new cements are brandnamed Graftys HBS and Graftys Quickset. Both, say the company, are injectable and resorbable calcium phosphate cements. Their indicated use is for treating subchondral bone marrow lesions. Also known as bone marrow edema, th...
